Skip to content

Effect of pentoxifylline in preventing contrast-induced nephropathy

The efficacy of pentoxifylline in prevention of contrast-induced nephropathy in patients with myocardial infarction undergoing coronary angioplasty: A randomized clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014092819316N1
Enrollment
182
Registered
2016-07-05
Start date
2013-10-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ST elevation myocardial infarction. Acute myocardial infarction

Interventions

Intervention 1: Intervention group: Normal saline (1-1.5 cc/kg from 6 hours before to 6 hours after coronary angioplasty) plus pentoxifylline (400 mg/tid from 24 h before to 24 h after coronary angiop
Treatment - Drugs
Intervention group: Normal saline (1-1.5 cc/kg from 6 hours before to 6 hours after coronary angioplasty) plus pentoxifylline (400 mg/tid from 24 h before to 24 h after coronary angioplasty).
Control group: Normal saline (1-1.5 cc/kg from six hours before to six hours after coronary angioplasty)

Sponsors

Vice chancellor for research of Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Consent to participate; ST elevation myocardial infarction (STMI) and age over 18 years. Exclusion criteria: serum creatinine more than 1.5 mg/dl, heart failure; history of end-stage renal failure or being on dialysis; use of N-acetyl cysteine, theophylline, aminoglycosides, and nonsteroidal anti-inflammatory drugs; intravenous contrast media administration within the past two days; pulmonary edema; multiple myeloma; and uncontrolled hypertension

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Serum creatinine levels. Timepoint: Before angioplasty, two days after angioplasty. Method of measurement: Blood test.;Contrast-induced nephropathy. Timepoint: 48 hours after angioplasty. Method of measurement: Blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Ali Eshraghi

Mashhad University of Medical Sciences

eshraghia@mums.ac.ir+98 51 3852 5307

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026